These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12073660)

  • 1. [Effects of piracetam on the cognitive functions verified by electrophysiologic methods].
    Kondákor I
    Orv Hetil; 2002 May; 143(20):1129-33. PubMed ID: 12073660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piracetam: novelty in a unique mode of action.
    Müller WE; Eckert GP; Eckert A
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():2-9. PubMed ID: 10338102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correspondence on ''the unrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production''.
    Duane DD
    J Child Neurol; 2009 Dec; 24(12):1578; author reply 1579. PubMed ID: 19955348
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental electroencephalographic study of piracetam in cats.
    Nikolova M
    Methods Find Exp Clin Pharmacol; 1981; 3(6):367-75. PubMed ID: 7329161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Piracetam and vigilance. A study of EEG changes and clinical effects in gerontopsychiatric patients (author's transl)].
    Bente D; Glatthaar G; Ulrich G; Lewinsky M
    Arzneimittelforschung; 1978; 28(9):1529-30. PubMed ID: 383104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
    Derev'yannykh EA; Bel'skaya GN; Knoll EA; Krylova LG; Popov DV
    Neurosci Behav Physiol; 2008 Oct; 38(8):873-5. PubMed ID: 18802768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL; Goldberg TE
    Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single doses of piracetam affect 42-channel event-related potential microstate maps in a cognitive paradigm.
    Michel CM; Lehmann D
    Neuropsychobiology; 1993; 28(4):212-21. PubMed ID: 8272204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piracetam improves visuomotor and cognitive deficits in early Parkinsonism--a pilot study.
    Oepen G; Eisele K; Thoden U; Birg W
    Pharmacopsychiatry; 1985 Nov; 18(6):343-6. PubMed ID: 4089014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of quetiapine on cognitive functions in schizophrenic patients: a preliminary single-trial ERP analysis.
    Zhang Y; Lehmann M; Shobeiry A; Höfer D; Johannes S; Emrich HM; Dietrich DE
    Pharmacopsychiatry; 2009 Jul; 42(4):129-34. PubMed ID: 19585390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvant therapy with parenteral piracetam in alcohol withdrawal delirium].
    Kalmár S
    Orv Hetil; 2003 May; 144(19):927-30. PubMed ID: 12809069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.
    Szalma I; Kiss A; Kardos L; Horváth G; Nyitrai E; Tordai Z; Csiba L
    Ann Thorac Surg; 2006 Oct; 82(4):1430-5. PubMed ID: 16996947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piracetam and brain excitability. An electrophysiological study in cats.
    Dimov S; Moyanova S; Nikolov R; Nikolova M
    Methods Find Exp Clin Pharmacol; 1984 Feb; 6(2):83-9. PubMed ID: 6717174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piracetam treatment in patients with cognitive impairment.
    Rao MG; Holla B; Varambally S; Raveendranathan D; Venkatasubramanian G; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(4):451.e5-6. PubMed ID: 22763000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.
    Aeby A; Poznanski N; Verheulpen D; Wetzburger C; Van Bogaert P
    Epilepsia; 2005 Dec; 46(12):1937-42. PubMed ID: 16393159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piracetam and event-related potentials in dyslexic children.
    Conners CK; Blouin AG; Winglee M; Lougee L; O'Donnell D; Smith A
    Psychopharmacol Bull; 1984; 20(4):667-73. PubMed ID: 6494392
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive ERPs are related to ApoE allelic variation in mildly cognitively impaired patients.
    Reinvang I; Espeseth T; Gjerstad L
    Neurosci Lett; 2005 Jul; 382(3):346-51. PubMed ID: 15925117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
    Bagadia VN; Gada MT; Mundra VK; Simon S; Doshi JM; Pradhan PV; Shah LP; Sheth UK
    J Postgrad Med; 1980 Apr; 26(2):116-20. PubMed ID: 7012328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.